Foundayo vs Ivim Health

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Foundayo vs Ivim Health: Overview

Choosing between Foundayo and Ivim Health for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Foundayo focuses on orforglipron at $149/month with a rating of 9.2/10. Ivim Health also provides both semaglutide and tirzepatide at $150/month with a 8.5/10 rating.

With only a $1/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$1/mo
Rating Difference
0.7
Winner
Foundayo
Best For
Budget

Foundayo

View full Foundayo review →
Rating
9.2/10Better
Monthly Price
$149Cheaper
Medications
orforglipron

Pros

  • The first and only FDA-approved GLP-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 April 2026
  • In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4% of body weight) against 2.2 pounds (0.9%) on placebo
  • Counting everyone randomised regardless of whether they finished, the average was still 25 pounds (11.1%) versus 5.3 pounds (2.1%) on placebo - Lilly published both numbers rather than only the flattering one
  • A once-daily tablet, so there is no injection, no needle disposal and no refrigeration to organise
  • Self-pay pricing is published up front at $149 per month for the lowest dose through LillyDirect, with free home delivery
  • Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card
  • Eligible Medicare Part D patients may be able to get it for $50 per month from as early as 1 July 2026 - a rarity in this category
  • Lilly reported reductions in waist circumference, non-HDL cholesterol, triglycerides and systolic blood pressure across all doses
  • It is a small-molecule (non-peptide) GLP-1, which is why it can be manufactured as a pill rather than an injection

Cons

  • Weight loss is meaningfully lower than the best injectables. 12.4% at the top dose sits below tirzepatide territory, so if maximum weight loss is the goal an injection still wins
  • It carries the class boxed warning: it may cause thyroid tumours including thyroid cancer, and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
  • Should not be used alongside another GLP-1 receptor agonist
  • Common side effects include nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, fatigue, heartburn, gas and hair loss
  • Serious risks in the label include pancreatitis, dehydration leading to kidney problems, gallbladder problems, severe allergic reactions and aspiration risk under anaesthesia
  • Safety and effectiveness in children have not been established
  • $149 is the price of the lowest dose only - higher doses cost more, and the $25 and $50 figures depend on insurance eligibility rather than being available to everyone
  • Very new to market, so there is no long-term real-world safety and adherence record yet
Choose Foundayo

Ivim Health

View full Ivim Health review →
Rating
8.5/10
Monthly Price
$150
Medications
semaglutidetirzepatide

Pros

  • The mandatory program fee is shown next to the medication price rather than buried in a footnote: compounded semaglutide from $75/mo and tirzepatide from $133/mo, each plus a $74.99/mo program fee (checked July 27, 2026)
  • Trustpilot rating of 4.9 from 38,826 reviews - the largest and strongest independent signal of any brand we have reviewed
  • Efficacy claims are sourced to Ivim's own published study, with the comparator spelled out and an explicit note that it was 'Not a head-to-head study'
  • The compounded, not-FDA-approved disclosure is stated plainly alongside the results claims rather than in a distant footer
  • The GLP-1 ID model offers weekly provider check-ins and weekly dose adjustments, which is more active titration support than most competitors provide
  • Brand-name options are available too - Wegovy pill, Foundayo pill, Zepbound, Mounjaro, Ozempic, Wegovy, Saxenda and liraglutide
  • Plan lengths are selectable at checkout (1, 2, 4 or 6 months) rather than defaulting to a single long commitment
  • This offer is restricted in only two states, Mississippi and Washington

Cons

  • The $74.99 monthly program fee effectively doubles the cost of the entry semaglutide plan, taking a '$75/mo' headline to about $150 all-in
  • The advertised 'starting at' rates depend on plan length, and the default 'Jumpstart' option is a 4-month commitment - so the cheapest prices are not available month to month
  • The headline result, that patients 'lost an average of 46% more weight over 68 weeks', comes from Ivim's own study rather than independent research, and the comparator was diet, exercise and counselling rather than another GLP-1 provider
  • Add-on benefits are quantified with unverifiable price tags - '1:1 Virtual Holistic Consultations $850 value' and 'Master classes, group coaching & community $500 value'
  • The weight-loss calculator produces a specific projection (41.8 lbs on the default settings) that no individual can rely on
  • The supplement catalogue is very large - collagen, NMN, creatine, colostrum, berberine and more - so there is a persistent upsell layer around the medical service
  • No published customer phone number or support hours
  • No BBB profile or complaint history to set against the Trustpilot score
Choose Ivim Health

Feature-by-feature comparison

FeatureFoundayoIvim Health
Monthly Price$149$150
Rating9.2/108.5/10
Medicationsorforglipronsemaglutide, tirzepatide
Insurance AcceptedYesNo
Support HoursNot publishedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedFree home delivery via LillyDirect; shipping began 6 April 2026Not published
Mobile AppNoAvailable
Dedicated CoachNot includedIncluded
Follow-up FrequencyAs directed by your prescriberWeekly provider check-ins with weekly dose adjustments
Money-back GuaranteeNone published; this is a prescription medicine, not a subscription serviceA refund policy is published; no blanket money-back guarantee is advertised
Cancellation PolicyPrescription-based - stopping treatment is a decision for you and your prescriberPrograms run for the duration selected at checkout - 1, 2, 4 or 6 months - with 4 months the default Jumpstart option

Which should you choose?

Choose Foundayo if you:

  • Want to save $1/month with a more affordable option
  • Prefer a higher-rated service (9.2/10 vs 8.5/10)
  • Need insurance coverage for your treatment
  • Value: the first and only fda-approved glp-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 april 2026

Choose Ivim Health if you:

  • Want more medication options to choose from
  • Want personalized coaching support included
  • Value: the mandatory program fee is shown next to the medication price rather than buried in a footnote: compounded semaglutide from $75/mo and tirzepatide from $133/mo, each plus a $74.99/mo program fee (checked july 27, 2026)

Website previews

Foundayo

Foundayo website

Ivim Health

Ivim Health website

Our recommendation

Foundayo comes out ahead with a higher rating of 9.2/10.
Get started with Foundayo

Compare other providers

Compare GLP-1 Brands